{
    "Trade/Device Name(s)": [
        "MAGO 4S",
        "MicroChemistry Analyzer",
        "MAGO 4S Automated EIA and IFA Processor"
    ],
    "Submitter Information": "Diamedix Corporation",
    "510(k) Number": "K093101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981729"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFX",
        "JJF"
    ],
    "Summary Letter Date": "December 1, 2010",
    "Summary Letter Received Date": "December 2, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3510"
    ],
    "Regulation Name(s)": [
        "Rubella virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG antibodies to rubella"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "MAGO 4S"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunoabsorbent assay (EIA)",
        "Immunofluorescence assay (IFA)",
        "Indirect enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Immunofluorescence"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Automated system",
        "Processor"
    ],
    "Document Summary": "FDA 510(k) summary for Diamedix MAGO 4S automated EIA and IFA analyzer for detection of rubella IgG in serum.",
    "Indications for Use Summary": "For qualitative, semi-quantitative, and quantitative detection of IgG antibodies to rubella in human serum by indirect enzyme immunoassay to assess immunological response and determine immune status, including in females of child-bearing age; aids diagnosis of current or recent rubella infection.",
    "fda_folder": "Microbiology"
}